Answers are grounded in this paper and cite their sources.
Despite the large number of new medicines entering the market every year, few offer important clinical advantages for patients. Huseyin Naci, Alexander Carter, and Elias Mossialos explain the reasons for this innovation deficit and offer some solutions
No takes yet. Share an insight, caveat, or question.
Naci et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: